IL106959A - Process for the preparation of carbapenem and penem derivatives and pharmaceutical compositions containing the derivatives prepared by said process - Google Patents

Process for the preparation of carbapenem and penem derivatives and pharmaceutical compositions containing the derivatives prepared by said process

Info

Publication number
IL106959A
IL106959A IL10695993A IL10695993A IL106959A IL 106959 A IL106959 A IL 106959A IL 10695993 A IL10695993 A IL 10695993A IL 10695993 A IL10695993 A IL 10695993A IL 106959 A IL106959 A IL 106959A
Authority
IL
Israel
Prior art keywords
derivatives
carbapenem
preparation
penem
pharmaceutical compositions
Prior art date
Application number
IL10695993A
Other languages
English (en)
Other versions
IL106959A0 (en
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL106959A0 publication Critical patent/IL106959A0/xx
Publication of IL106959A publication Critical patent/IL106959A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Eye Examination Apparatus (AREA)
IL10695993A 1992-09-09 1993-09-09 Process for the preparation of carbapenem and penem derivatives and pharmaceutical compositions containing the derivatives prepared by said process IL106959A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24082592 1992-09-09
JP32511492 1992-12-04

Publications (2)

Publication Number Publication Date
IL106959A0 IL106959A0 (en) 1993-12-28
IL106959A true IL106959A (en) 2000-06-01

Family

ID=26534948

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10695993A IL106959A (en) 1992-09-09 1993-09-09 Process for the preparation of carbapenem and penem derivatives and pharmaceutical compositions containing the derivatives prepared by said process

Country Status (21)

Country Link
EP (1) EP0587436B1 (da)
KR (1) KR100300365B1 (da)
CN (1) CN1048494C (da)
AT (1) ATE192747T1 (da)
AU (1) AU661793B2 (da)
CA (1) CA2105746A1 (da)
CZ (1) CZ287608B6 (da)
DE (1) DE69328600T2 (da)
DK (1) DK0587436T3 (da)
ES (1) ES2147743T3 (da)
FI (1) FI104822B (da)
GR (1) GR3033555T3 (da)
HK (1) HK1011975A1 (da)
HU (1) HUT65301A (da)
IL (1) IL106959A (da)
MX (1) MX9305548A (da)
NO (1) NO304981B1 (da)
NZ (1) NZ248629A (da)
PT (1) PT587436E (da)
RU (1) RU2070555C1 (da)
TW (1) TW368503B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
IN191798B (da) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862198D1 (en) * 1977-08-06 1983-04-14 Beecham Group Plc Synthetic beta-lactam compounds, a process for their preparation and compositions containing them
EP0046363B1 (en) * 1980-08-16 1984-11-14 Beecham Group Plc Process for the preparation of 2-thio penem derivatives and intermediates therefor
EP0060612A1 (en) * 1981-02-04 1982-09-22 Beecham Group Plc Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives
EP0061231A1 (en) * 1981-02-04 1982-09-29 Beecham Group Plc Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives
US4640915A (en) * 1982-03-29 1987-02-03 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid derivatives
JPS5946288A (ja) * 1982-09-10 1984-03-15 Sanraku Inc β−ラクタム誘導体の製造方法
EP0120613A1 (en) * 1983-03-02 1984-10-03 Beecham Group Plc Penem derivatives and precursors
US4614738A (en) * 1983-03-25 1986-09-30 Schering Corporation 2-(N-heterocycloaliphaticthio)penems
US4614737A (en) * 1983-10-14 1986-09-30 Pfizer Inc. 2-dioxacycloalkylthiopenem derivatives
US4820817A (en) * 1984-09-10 1989-04-11 Merck & Co., Inc. Process for preparing 3-substituted-6-substituted-7-oxo-1-azabicycl(3.2.0)-hept-2-ene-2-carboxylic acid

Also Published As

Publication number Publication date
HK1011975A1 (en) 1999-07-23
FI933926A0 (fi) 1993-09-08
MX9305548A (es) 1994-04-29
HU9302547D0 (en) 1993-11-29
FI104822B (fi) 2000-04-14
KR940007031A (ko) 1994-04-26
NO933195D0 (no) 1993-09-08
AU661793B2 (en) 1995-08-03
CZ287608B6 (en) 2001-01-17
ATE192747T1 (de) 2000-05-15
RU2070555C1 (ru) 1996-12-20
NZ248629A (en) 1995-04-27
CA2105746A1 (en) 1994-03-10
FI933926A (fi) 1994-03-10
DK0587436T3 (da) 2000-08-07
EP0587436B1 (en) 2000-05-10
ES2147743T3 (es) 2000-10-01
DE69328600T2 (de) 2001-02-08
CZ187493A3 (en) 1994-04-13
NO304981B1 (no) 1999-03-15
DE69328600D1 (de) 2000-06-15
HUT65301A (en) 1994-05-02
CN1048494C (zh) 2000-01-19
GR3033555T3 (en) 2000-09-29
AU4624393A (en) 1994-03-17
PT587436E (pt) 2000-10-31
KR100300365B1 (ko) 2001-11-22
CN1094728A (zh) 1994-11-09
IL106959A0 (en) 1993-12-28
NO933195L (no) 1994-03-10
TW368503B (en) 1999-09-01
EP0587436A1 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
HK65390A (en) Infra-red absorber
HUT66660A (en) Intermediates for producing 9-[(substituted glicyl)-amido]-6-demetyl-6-deoxy-tetracyclines and pharmaceutical compositions containing them
AU1962892A (en) Cephalosporin compounds, processes for their preparation and antibacterial agents
HUT47128A (en) Process for producing oxetanocins and pharmaceutical compositions comprising such compounds
IL106959A (en) Process for the preparation of carbapenem and penem derivatives and pharmaceutical compositions containing the derivatives prepared by said process
AU5486694A (en) Lactone compound and process of production thereof
EP0669336A4 (en) NEW CEPHEM DERIVATIVES.
NZ240404A (en) Oxysulphonyl (thio)carbamate derivatives and pharmaceutical
ATE237619T1 (de) Sesquiterpen-derivate mit antiviraler aktivität
AU3210593A (en) Improvements in or relating to organic compounds
RU93050367A (ru) Способ получения карбапенемовых и пенемовых соединений и промежуточные соединения
DK0567767T3 (da) Krystallinske former af endo-2,3-dihydro-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2-oxo-1H-benzimidazol-1-carboxamid-hydroc
AU2532692A (en) Method for treating hypertension
AU4706489A (en) Oxadiazol-azabicycl compounds and their pharmaceutical use
JPS57163362A (en) Azetidinone derivative and its preparation
EP0404104A3 (en) Angolamycin derivatives
IL109227A0 (en) Leustroducsin h, pharmaceutical composition containing the same, and processes for the preparation thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force